API
< Back to all clusters
[HEALTH] · Brazil · 8 sources

started · updated

Brazil clinical research participation rises under new legal framework

Brazil's participation in global clinical research has increased following the implementation of a new legal framework. According to data from the Association of the Pharmaceutical Research Industry (Interfarma), Brazil's ranking among countries conducting these tests rose from 18th to 12th between 2025 and the first half of 2026.

Interfarma projects that Brazil could soon reach the 10th position, supported by anticipated annual investments exceeding R$ 2 billion. The progress follows the enactment of Law 14.874, known as the Clinical Research Law, which was sanctioned in May 2024 and regulated in October 2025. This legislation provides the first dedicated legal framework for the sector in Brazil, which was previously governed only by norms from the National Health Council and the National Health Surveillance Agency (Anvisa).

The new law established the National System of Ethics in Research Involving Humans, reorganizing committee workflows and shortening analysis timelines. For instance, ethical opinions must now be issued within 30 business days.

Entities

Anvisa · Interfarma · National Health Council